| Literature DB >> 35629111 |
Giuseppe Caminiti1, Marco Alfonso Perrone2, Ferdinando Iellamo1,2, Valentino D'Antoni1, Matteo Catena1, Alessio Franchini1, Maurizio Volterrani1.
Abstract
In this study, we aimed to assess acute changes occurring on atrial function following single bouts of eccentric resistance exercise (ECC-RE) performed at two different loads. Twenty-five patients with chronic heart failure with middle range ejection fraction (HFmrEF) participated in three experimental sessions in a randomized order and on separate days: two sessions of ECC RE at 20% (ECC-20) of one-repetition maximum (1-RM) and 50% (ECC-50) 1-RM, and one session of control, without exercise. Each session lasted three minutes. Before and immediately after the sessions, patients underwent echocardiography and blood pressure and heart rate measurement. Peak atrial longitudinal strain (PALS) and peak atrial contractile strain (PACS) significantly increased after both ECC-20 (+16.3%) and ECC-50 (+18.1%) compared to control (between sessions p = 0.022). Peak atrial contractile strain (PACS) significantly increased after ECC-50 (+28.4%) compared to ECC-20 (+17.0%) and control (between sessions p = 0.034). The ratio of transmitral and annular velocities (E/E') increased significantly after ECC-20 (+10.4%) and ECC-50 (+19.0%) compared to control (between groups p = 0.003). EF, left ventricular longitudinal strain, and stroke volume did not change after ECC-RE sessions compared to control. Cardiac output increased significantly after ECC-20 and ECC-50 compared to control, (between groups p = 0.025). In conclusion, both ECC-RE sessions were well tolerated, and LA functional reserve was properly mobilized in response to ECC-RE in patients with HFmrEF. Cardiac output increased at the cost of an increased LV filling pressure, but no detrimental changes of LV function occurred.Entities:
Keywords: atrial function; eccentric exercise; heart failure; resistance exercise; ventricular strain
Year: 2022 PMID: 35629111 PMCID: PMC9145268 DOI: 10.3390/jpm12050689
Source DB: PubMed Journal: J Pers Med ISSN: 2075-4426
Figure 1Study flowchart.
Anthropometric and clinical characteristics of patients.
| Age, years | 71.4 ± 7.5 |
| BMI, kg/m2 | 27.5 ± 6.3 |
| Waist circumference, cm | 104.2 ± 31.6 |
| Male/female | 20/5 |
| Previous PCI/CABG | 16/14 |
| NYHA class (II-III) | 19/6 |
| EF (%) | 46.7± 6.2 |
| NT-pro BNP | 465.0 ± 59.3 |
|
| |
| Carotid artery disease, | 13 (52) |
| Hypertension, | 25/(100) |
| Diabetes, | 6 (24) |
| Hypercholesterolemia, | 21 (84) |
| Previous Smoke habit, | 18 (60) |
|
| |
| Anti-platelets agents, | 25 (100) |
| ACE-Is/ARBs, | 22 (88) |
| Betablockers, | 18 (60) |
| Diuretics, | 8 (32) |
| Statins, | 25 (100) |
BMI, body mass index; EF, ejection fraction; ACE-Is, angiotensin-converting enzyme inhibitors; ARBs, angiotensin receptor blockers.
Hemodynamic and echocardiography parameters before (T0) and after (T1) exercise sessions.
| ECC-20% | ECC-50% | Control | ||||
|---|---|---|---|---|---|---|
| T0 | T1 | T0 | T1 | T0 | T1 | |
|
| 61.2 ± 22.4 | 68.6 ± 23.2 * | 64.5 ± 27.5 | 71.2 ± 31.8 * | 64.1 ± 26.6 | 66.2 ± 25.7 |
|
| 113.6 ± 28.2 | 132.7 ± 25.6 * | 107.8 ± 23.5 | 133.7 ± 19.4 * | 109.2 ± 39.6 | 107.4 ± 28.4 |
|
| 74.1 ± 11.5 | 78.4 ± 10.4 | 73.6 ± 17.1 | 75.5 ± 10.8 | 73,9 ± 13.3 | 74.0 ± 15.8 |
|
| 87.8 ± 11.6 | 94.8 ± 9.6 * | 87.2 ± 13.7 | 96.3 ± 11.1 * | 87.2 ± 13.7 | 87.2 ± 13.7 |
|
| 69.5 ± 13.3 | 91.0 ± 22.1 | 68.4 ± 17.7 | 95.2 ± 19.4 | 68.3 ± 20.5 | 68.4 ± 16.9 |
|
| 28.2 ± 8.2 | 32.7 ± 11.6 * | 28.2 ± 10.1 | 33.5 ± 8.4 * | 28.2 ± 10.1 | 28.6 ± 7.3 |
|
| 14.0 ± 3.6 | 16.7 ± 3.8 * | 14.2 ± 3.7 | 18.5 ± 4.6 * † | 14.5 ± 2.9 | 14.3 ± 3.4 |
|
| 33.4 ± 5.1 | 32.9 ± 3.9 | 33.2 ± 4.7 | 33.5 ± 5.0 | 33.2 ± 4.3 | 33.6 ± 6.5 |
|
| 125.6 ±34.5 | 123.4 ± 40.4 | 123.7 ± 36.2 | 126.2 ± 26.9 | 125.9 ± 30.4 | 126.0 ± 28.7 |
|
| 67.2 ± 26.3 | 62.9 ± 24.9 | 62.3 ± 18.4 | 65.3 ± 22.1 | 66.4 ± 19.5 | 67.1 ± 20.8 |
|
| 57.7 ± 17.88 | 71.6 ± 21.3 | 55.6 ± 18.7 | 71.2 ± 15.6 | 57.1 ± 16.0 | 58.3 ± 17.1 |
|
| 59.4 ± 22.6 | 68.5 ± 16.8 | 58.3 ± 19.5 | 73.3 ± 16.2 | 58.4 ± 19.2 | 61.2 ± 21.0 |
|
| 6.7 ± 1.5 | 7.5 ± 2.2 * | 7.0 ± 1.9 | 7.5 ± 1.4 * | 6.6 ± 2.0 | 6.8 ± 1.8 |
|
| 5.8 ± 1.4 | 7.1 ± 3.0 * | 5.4 ± 1.4 | 7.8 ± 3.0 * | 56 ± 1.9 | 5.8 ± 2.2 |
|
| 8.6 ± 1.7 | 9.5 ± 1.9 * | 7.9 ± 2.5 | 9.4 ± 1.4 * | 8.3 ± 2.2 | 8.1 ± 1.9 |
|
| 0.30 ± 0.2 | 0.29 ± 0.4 | 0.28 ± 0.2 | 0.28 ± 0.3 | 0.29 ± 0.4 | 0.28 ± 0.3 |
|
| 68.9 ± 8.3 | 76.3 ± 10.5 * | 63.8 ± 11.8 | 74.4 ± 12.0 * | 65.9 ± 15.2 | 64.2 ± 9.7 |
|
| 46.2 ± 3.6 | 46.8 ± 2.8 | 45.9 ± 4.5. | 46.1 ± 3.3 | 46.3 ± 5.1 | 46.1 ± 3.9 |
|
| −13.8 ± 1.7 | −16.3 ± 2.2 | −13.1 ± 1.8 | −14.6 ± 2.4 | −13.4 ± 2.4 | −13.5 ± 1.9 |
|
| 58.4 ± 17.3 | 56.1 ± 11.0 | 61.4 ± 19.2 | 62.8 ± 16.8 | 61.4 ± 13.2 | 60.9 ± 18.7 |
|
| 3.5 ± 1.5 | 4.1 ± 1.3 * | 3.7 ± 1.2 | 4.2 ± 1.8 * | 3.6 ± 1.7 | 3.7 ± 1.5 |
HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; EDV, end-diastolic volume; ESV, end-systolic volume; PALS, peak atrial longitudinal strain; PACS, peak atrial contraction strain; GLS, global longitudinal strain; SV, stroke volume; CO, cardiac output. * p < 0.05 vs. control. † p < 0.05 vs. intervention.
Figure 2Percentage changes of PALS and PACS after ECC-20 (black-bars), ECC-50 (gray-bars) and control session (dotted bars). Results of ANOVA and post hoc testing.